US Stock MarketDetailed Quotes

Alnylam Pharmaceuticals (ALNY)

Watchlist
  • 370.000
  • +4.540+1.24%
Close Jan 22 16:00 ET
  • 370.000
  • 0.0000.00%
Post 20:01 ET
48.88BMarket Cap1233.33P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Alnylam Pharmaceuticals (ALNY) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/Q3
Stock NameRevenueRatio
AMVUTTRA685.3M54.87%
Net revenues from collaborations351.74M28.16%
GIVLAARI73.87M5.91%
OXLUMO52.83M4.23%
Royalty revenue46.2M3.70%
ONPATTRO39.08M3.13%
View all

By Country/Region

Currency:USD
2024/FY
Stock NameRevenueRatio
United States933.54M41.52%
Europe516.3M22.96%
Net revenues from collaborations510.22M22.69%
Rest of world196.39M8.74%
Royalty revenue91.79M4.08%
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -